» Authors » P Cottagnoud

P Cottagnoud

Explore the profile of P Cottagnoud including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 50
Citations 277
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Stucki A, Acosta F, Cottagnoud M, Cottagnoud P
Antimicrob Agents Chemother . 2013 Sep; 57(12):5808-10. PMID: 24002097
In this study, the efficacy of ceftaroline fosamil was compared with that of cefepime in an experimental rabbit meningitis model against two Gram-negative strains (Escherichia coli QK-9 and Klebsiella pneumoniae...
2.
Cottagnoud P, Cottagnoud M, Acosta F, Stucki A
Antimicrob Agents Chemother . 2013 Jul; 57(10):4653-5. PMID: 23836180
Ceftaroline is a new cephalosporin with bactericidal activity against resistant Gram-positive organisms, including methicillin-resistant Staphylococcus aureus (MRSA) and penicillin-resistant Streptococcus pneumoniae, as well as common Gram-negative organisms. This study tested...
3.
Pavlov N, Strebel B, Brill A, Schmidtko J, Cottagnoud P, Stucki A
Praxis (Bern 1994) . 2013 Feb; 102(4):233-6. PMID: 23399608
We report the case of a 28-years-old woman with Turner's syndrome and iron deficiency anaemia. The faecal occult blood test was intermittently positive whereas earlier upper and lower endoscopy revealed...
4.
Pavlov N, Wermelinger F, Stucki A, Cottagnoud P
Praxis (Bern 1994) . 2012 Nov; 101(22):1441-4. PMID: 23117965
We report the case of a 58-years-old soldier with a history of movement related neck pain, weight loss and exercise intolerance. Blood tests presented signs of an inflammatory syndrome. The...
5.
Stucki A, Cottagnoud M, Acosta F, Egerman U, Lauffer J, Cottagnoud P
Antimicrob Agents Chemother . 2011 Nov; 56(2):921-5. PMID: 22064544
Ceftobiprole medocaril, a new cephalosporin, is highly active against a broad spectrum of Gram-positive and Gram-negative clinical pathogens, including methicillin-resistant Staphylococcus aureus (MRSA) and penicillin-resistant pneumococci. In this study, we...
6.
Egermann U, Stanga Z, Ramin A, Acosta F, Stucki A, Gerber P, et al.
Antimicrob Agents Chemother . 2009 Apr; 53(7):3030-3. PMID: 19364870
We examined the cerebrospinal fluid penetration of daptomycin after the addition of dexamethasone and its bactericidal efficacy with and without ceftriaxone in an experimental rabbit model of pneumococcal meningitis. The...
7.
Vetter C, Robert-Tissot L, Cottagnoud P, Stucki A
Praxis (Bern 1994) . 2008 Jun; 97(8):437-42. PMID: 18551914
From medical view the main problems of investigation and convicts are in particular in the range of the drugs and alcohol illnesses to see transferable diseases (HIV, hepatitis B -...
8.
Schmidtko J, Truninger K, Gugger M, Cottagnoud P, Stucki A
Praxis (Bern 1994) . 2008 Jun; 97(3):117-8. PMID: 18549011
No abstract available.
9.
Hohl A, Vogel C, Cottagnoud P, Stanga Z, Chatterjee B, Stucki A
Praxis (Bern 1994) . 2007 May; 96(18):739-41. PMID: 17520843
No abstract available.
10.
Stucki A, Cottagnoud M, Winkelmann V, Schaffner T, Cottagnoud P
Antimicrob Agents Chemother . 2007 Mar; 51(6):2249-52. PMID: 17371817
Daptomycin monotherapy was superior to ceftriaxone monotherapy and was highly efficacious in experimental pneumococcal meningitis, sterilizing the cerebrospinal fluid (CSF) of three of three rabbits after 4 to 6 h....